Literature DB >> 22179250

Real-time PCR analysis of the intestinal microbiotas in peritoneal dialysis patients.

I-Kuan Wang1, Hsueh-Chou Lai, Cheng-Ju Yu, Chih-Chia Liang, Chiz-Tzung Chang, Huey-Liang Kuo, Ya-Fei Yang, Chung-Chih Lin, Hsin-Hung Lin, Yao-Lung Liu, Yi-Chih Chang, Yi-Ying Wu, Chu-Huang Chen, Chi-Yuan Li, Feng-Rong Chuang, Chiu-Ching Huang, Chih-Hsueh Lin, Hung-Chih Lin.   

Abstract

Bifidobacterium and Lactobacillus can beneficially affect the host by producing acetic acid and lactic acid, which lower pH and thereby inhibit the growth of pathogens or allow the probiotic bacteria to compete with pathogens for epithelial adhesion sites and nutrients. The transmural migration of enteric organisms into the peritoneal cavity can cause peritonitis in peritoneal dialysis (PD) patients. We hypothesized that the composition of the intestinal microbiota with regard to Lactobacillus species and Bifidobacterium species differed between PD patients and healthy controls. The aim of the study was to investigate these differences by real-time PCR analysis of fecal samples. From 1 August 2009 to 31 March 2010, a total of 29 nondiabetic PD patients and 41 healthy controls from China Medical University Hospital were recruited after giving their informed consent. Fecal samples were collected from the PD patients and their age-matched counterparts in the morning using a standardized procedure. DNA extracted from these samples was analyzed by real-time PCR. All bifidobacteria, Bifidobacterium catenulatum, B. longum, B. bifidum, Lactobacillus plantarum, L. paracasei, and Klebsiella pneumoniae were less frequently detected in the patient samples. Dysbiosis (microbial imbalance) may impair intestinal barrier function and increase host vulnerability to pathogen invasion. Further studies are necessary to confirm our findings before clinical trials with probiotic supplementation in PD patients.

Entities:  

Mesh:

Year:  2011        PMID: 22179250      PMCID: PMC3273023          DOI: 10.1128/AEM.05605-11

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  37 in total

1.  Extensive set of 16S rRNA-based probes for detection of bacteria in human feces.

Authors:  Hermie J M Harmsen; Gerwin C Raangs; Tao He; John E Degener; Gjalt W Welling
Journal:  Appl Environ Microbiol       Date:  2002-06       Impact factor: 4.792

2.  Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria.

Authors:  N Borruel; M Carol; F Casellas; M Antolín; F de Lara; E Espín; J Naval; F Guarner; J R Malagelada
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

3.  Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease.

Authors:  Natarajan Ranganathan; Pari Ranganathan; Eli A Friedman; Anthony Joseph; Barbara Delano; David S Goldfarb; Paul Tam; A Venketeshwer Rao; Emmanuel Anteyi; Carlos Guido Musso
Journal:  Adv Ther       Date:  2010-08-16       Impact factor: 3.845

Review 4.  The enteric microbiota in the pathogenesis and management of constipation.

Authors:  E M M Quigley
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-02       Impact factor: 3.043

5.  Application of the fluorogenic probe technique (TaqMan PCR) to the detection of Enterococcus spp. and Escherichia coli in water samples.

Authors:  Edith Frahm; Ursula Obst
Journal:  J Microbiol Methods       Date:  2003-01       Impact factor: 2.363

6.  Food intake characteristics of hemodialysis patients as obtained by food frequency questionnaire.

Authors:  Kamyar Kalantar-Zadeh; Joel D Kopple; Sunaina Deepak; Donald Block; Gladys Block
Journal:  J Ren Nutr       Date:  2002-01       Impact factor: 3.655

7.  Quantification of bacteria adherent to gastrointestinal mucosa by real-time PCR.

Authors:  Xander W Huijsdens; Ronald K Linskens; Mariëtte Mak; Stephan G M Meuwissen; Christina M J E Vandenbroucke-Grauls; Paul H M Savelkoul
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

8.  Prevalence of constipation in continuous ambulatory peritoneal dialysis patients and comparison with hemodialysis patients.

Authors:  Gen Yasuda; Kazuhiko Shibata; Toshikazu Takizawa; Yumiko Ikeda; Yasuo Tokita; Satoshi Umemura; Osamu Tochikubo
Journal:  Am J Kidney Dis       Date:  2002-06       Impact factor: 8.860

9.  Application of quantitative real-time PCR for rapid identification of Bacteroides fragilis group and related organisms in human wound samples.

Authors:  Jia Tong; Chengxu Liu; Paula Summanen; Huaxi Xu; Sydney M Finegold
Journal:  Anaerobe       Date:  2011-03-23       Impact factor: 3.331

10.  Probiotic properties of Lactobacillus strains isolated from the feces of breast-fed infants and Taiwanese pickled cabbage.

Authors:  Chung-Yi Wang; Pei-Rong Lin; Chang-Chai Ng; Yuan-Tay Shyu
Journal:  Anaerobe       Date:  2010-10-15       Impact factor: 3.331

View more
  34 in total

1.  Progressive inflammation and wasting in patients with ESRD.

Authors:  George A Kaysen
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

Review 2.  Gut Microbiome in Chronic Kidney Disease.

Authors:  R G Armani; A Ramezani; A Yasir; S Sharama; M E F Canziani; D S Raj
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

3.  Development of a bead-based suspension array for the detection of pathogens in acute respiratory tract infections.

Authors:  Yu-Sheng Chen; Hong-Ru Li; Wei Zhang; Zhi-Dan Hua; Xiao-Hong Lin; Meng-Qing Lin; Wen-Sen Huang; Li-Ping Huang; Xiao-Li Yu; Neng-Luan Xu; Ming Lin; Bao-Song Xie; Xiao-Na Shen; Jian-Feng Xie; Yi Wang; Meng Huang; Yan-An Wu; Xin-Lan Hu
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-13

4.  A Renal Clinician's Guide to the Gut Microbiota.

Authors:  Matthew Snelson; Annabel Biruete; Catherine McFarlane; Katrina Campbell
Journal:  J Ren Nutr       Date:  2020-01-09       Impact factor: 3.655

Review 5.  The gut-kidney axis.

Authors:  Pieter Evenepoel; Ruben Poesen; Björn Meijers
Journal:  Pediatr Nephrol       Date:  2016-11-15       Impact factor: 3.714

6.  Comamonas testosteroni-associated peritonitis in a pediatric peritoneal dialysis patient.

Authors:  Mattia Parolin; Maura Baraldi; Elena Valentini; Luisa Murer; Enrico Vidal
Journal:  World J Nephrol       Date:  2016-03-06

7.  Gastrointestinal Microbiota in Patients with Chronic Kidney Disease: A Systematic Review.

Authors:  SeonYoon Chung; Jennifer L Barnes; Kim Schafer Astroth
Journal:  Adv Nutr       Date:  2019-09-01       Impact factor: 8.701

8.  Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD.

Authors:  Eikan Mishima; Shinji Fukuda; Hisato Shima; Akiyoshi Hirayama; Yasutoshi Akiyama; Yoichi Takeuchi; Noriko N Fukuda; Takehiro Suzuki; Chitose Suzuki; Akinori Yuri; Koichi Kikuchi; Yoshihisa Tomioka; Sadayoshi Ito; Tomoyoshi Soga; Takaaki Abe
Journal:  J Am Soc Nephrol       Date:  2014-12-18       Impact factor: 10.121

9.  Characterization of the gut microbiota in patients with primary sclerosing cholangitis compared to inflammatory bowel disease and healthy controls.

Authors:  Samaneh Ostadmohammadi; Masoumeh Azimirad; Hamidreza Houri; Kaveh Naseri; Ehsan Javanmard; Hamed Mirjalali; Abbas Yadegar; Amir Sadeghi; Hamid Asadzadeh Aghdaei; Mohammad Reza Zali
Journal:  Mol Biol Rep       Date:  2021-07-25       Impact factor: 2.316

10.  Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: A randomized controlled trial.

Authors:  İlkay Yılmaz; M Enver Dolar; Haydar Özpınar
Journal:  Turk J Gastroenterol       Date:  2019-03       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.